| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |